The macrophage mediates the renoprotective effects of endotoxin preconditioning

Journal of the American Society of Nephrology

Volumn 26, Issue 6, 2015, Pages 1347-1362

  Hato, Takashi ^a   Winfree, Seth ^a   Kalakeche, Rabih ^a   Dube, Shataakshi ^a   Kumar, Rakesh ^a   Yoshimoto, Momoko ^a   Plotkin, Zoya ^a   Dagher, Pierre C ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEME OXYGENASE 1; KIDNEY INJURY MOLECULE 1; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIRTUIN 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; CYTOKINE; REACTIVE OXYGEN METABOLITE; TLR4 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; HEMATOPOIETIC CELL; IMMUNOCOMPETENT CELL; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KIDNEY TUBULE DAMAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; SEPSIS; SIGNAL TRANSDUCTION; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENETICS; ISCHEMIC PRECONDITIONING; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD14; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXINS; ISCHEMIC PRECONDITIONING; KIDNEY TUBULES, PROXIMAL; MALE; MICE; OXIDATIVE STRESS; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; SEPSIS; TOLL-LIKE RECEPTOR 4;

EID: 84930425750     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014060561     Document Type: Article

References (57)

1. Murugan R, Kellum JA: Acute kidney injury: What's the prognosis? Nat Rev Nephrol 7: 209-217, 2011
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36: 296-327, 2008
3. El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dagher PC: Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 290: F1034-F1043, 2006
4. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859, 2007
5. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, Leemans JC: Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3: e3596, 2008
6. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033, 2002
7. Good DW, George T, Watts BA 3rd: Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol 297: F866-F874, 2009
8. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van 't Veer C: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated upregulation during inflammation. J Immunol 168: 1286-1293, 2002
9. Kalakeche R, Hato T, Rhodes G, Dunn KW, El-Achkar TM, Plotkin Z, Sandoval RM, Dagher PC: Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol 22: 1505-1516, 2011
10. Chao W: Toll-like receptor signaling: A critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 296: H1-H12, 2009
11. Lehner MD, Ittner J, Bundschuh DS, van Rooijen N, Wendel A, Hartung T: Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun 69: 463-471, 2001
12. Foster SL, Hargreaves DC, Medzhitov R: Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978, 2007
13. Slofstra SH, ten Cate H, Spek CA: Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction. Thromb J 4: 13, 2006
14. Biswas SK, Lopez-Collazo E: Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol 30:475-487, 2009
15. Wheeler DS, Lahni PM, Denenberg AG, Poynter SE, Wong HR, Cook JA, Zingarelli B: Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30: 267-273, 2008
16. Shi DW, Zhang J, Jiang HN, Tong CY, Gu GR, Ji Y, Summah H, Qu JM: LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm Res 60: 841-849, 2011
17. Lehner MD, Hartung T: Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection. Rev Physiol Biochem Pharmacol 144: 95-141, 2002
18. Godet C, Goujon JM, Petit I, Lecron JC, Hauet T, Mauco G, Carretier M, Robert R: Endotoxin tolerance enhances interleukin-10 renal expression and decreases ischemia-reperfusion renal injury in rats. Shock 25: 384-388, 2006
19. Heemann U, Szabo A, Hamar P, Müller V, Witzke O, Lutz J, Philipp T: Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: Possible connection to an interleukin-6-dependent pathway. Am J Pathol 156: 287-293, 2000
20. Vogt BA, Alam J, Croatt AJ, Vercellotti GM, Nath KA: Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest 72: 474-483, 1995
21. Zager RA, Johnson AC, Lund S: 'Endotoxin tolerance': TNF-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int 71: 496-503, 2007
22. Usuda N, Yokota S, Hashimoto T, Nagata T: Immunocytochemical localization of D-amino acid oxidase in the central clear matrix of rat kidney peroxisomes. J Histochem Cytochem 34: 1709-1718, 1986
23. Bonekamp NA, Völkl A, Fahimi HD, Schrader M: Reactive oxygen species and peroxisomes: Struggling for balance. Biofactors 35: 346-355, 2009
24. Schrader M, Fahimi HD: Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-1766, 2006
25. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC: CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147: 868-880, 2011
26. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B: CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570, 2005
27. Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP: LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J Neuroinflammation 8: 140, 2011
28. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V: Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 179: 4083-4092, 2007
29. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR: Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106-4114, 2000
30. De Wilde V, Van Rompaey N, Hill M, Lebrun JF, Lemaître P, Lhommé F, Kubjak C, Vokaer B, Oldenhove G, Charbonnier LM, Cuturi MC, Goldman M, Le Moine A: Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 9: 2034-2047, 2009
31. Gozzelino R, Jeney V, Soares MP: Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354, 2010
32. Liu TF, Yoza BK, El Gazzar M, Vachharajani VT, McCall CE: NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance. J Biol Chem 286: 9856-9864, 2011
33. Shen Z, Ajmo JM, Rogers CQ, Liang X, Le L, Murr MM, Peng Y, You M: Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol 296: G1047-G1053, 2009
34. Tzima S, Victoratos P, Kranidioti K, Alexiou M, Kollias G: Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J Exp Med 206: 1167-1179, 2009
35. Zhang Z, Lowry SF, Guarente L, Haimovich B: Roles of SIRT1 in the acute and restorative phases following induction of inflammation. J Biol Chem 285: 41391-41401, 2010
36. Ferenbach DA, Nkejabega NC, McKay J, Choudhary AK, Vernon MA, Beesley MF, Clay S, Conway BC, Marson LP, Kluth DC, Hughes J: The induction of macrophage hemeoxygenase-1 is protective during acute kidney injury in aging mice. Kidney Int 79: 966-976, 2011
37. Zarjou A, Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol 22: 999-1006, 2011
38. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA: Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 170: 1820-1830, 2007
39. Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, Marguti I, Cardoso S, Sepúlveda N, Smith A, Soares MP: A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2: 51ra71, 2010
40. Nathan C, Cunningham-Bussel A: Beyond oxidative stress: An immunologist's guide to reactive oxygen species. Nat Rev Immunol 13: 349-361, 2013
41. Wu L, Gokden N, Mayeux PR: Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 18: 1807-1815, 2007
42. Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, Bauer M, Riedemann NC: The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care 15: R183, 2011
43. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A: The new normal: Immunomodulatory agents against sepsis immune suppression. Trends Mol Med 20: 224-233, 2014
44. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG: The pathogenesis of sepsis. Annu Rev Pathol 6: 19-48, 2011
45. Deutschman CS, Tracey KJ: Sepsis: Current dogma and new perspectives. Immunity 40: 463-475, 2014
46. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk HD: Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180: 640-648, 2009
47. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: A new skin for the old ceremony. Mol Med 14: 64-78, 2008
48. Schaer DJ, Buehler PW, Alayash AI, Belcher JD, Vercellotti GM: Hemolysis and free hemoglobin revisited: Exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121: 1276-1284, 2013
49. Baek JH, D'Agnillo F, Vallelian F, Pereira CP, Williams MC, Jia Y, Schaer DJ, Buehler PW: Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest 122: 1444-1458, 2012
50. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K: Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24: 353-389, 2006
51. Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H: Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis 39: 596-603, 2007
52. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G: Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 177: 6540-6547, 2006
53. Zanoni I, Granucci F: Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol 3: 32, 2013
54. Hiemstra TF, Charles PD, Gracia T, Hester SS, Gatto L, Al-Lamki R, Floto RA, Su Y, Skepper JN, Lilley KS, Karet Frankl FE: Human urinary exosomes as innate immune effectors [published online ahead of print April 3, 2014]. J Am Soc Nephrol
55. Triantafilou K, Triantafilou M, Fernandez N: Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies. Cytometry 41: 316-320, 2000
56. Dunn KW, Sandoval RM, Kelly KJ, Dagher PC, Tanner GA, Atkinson SJ, Bacallao RL, Molitoris BA: Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol 283: C905-C916, 2002
57. Sutton TA, Hato T, Mai E, Yoshimoto M, Kuehl S, Anderson M, Mang H, Plotkin Z, Chan RJ, Dagher PC: p53 is renoprotective after ischemic kidney injury by reducing inflammation. J Am Soc Nephrol 24: 113-124, 2013